Amgen Inc.

AMGN-Q

NASDAQ:AMGN

258.60
1.50 (0.58%)
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world's largest independent biotechnology firm.
More at Wikipedia

Analysis and Opinions about AMGN-Q

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
April 1, 2010
(A Top Pick April 21/09. Up 29.83%.) Sold his holdings at a good gain.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
April 1, 2010
(A Top Pick April 21/09. Up 29.83%.) Sold his holdings at a good gain.
BUY WEAKNESS
BUY WEAKNESS
October 14, 2009
Largest biotech stock in the US. He prefers biotech to pharma. This one is quite a reasonable company but thinks the markets are a little overdone at these levels. You won't go too far wrong but try to get it in the mid-to low $50's.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
October 14, 2009
Largest biotech stock in the US. He prefers biotech to pharma. This one is quite a reasonable company but thinks the markets are a little overdone at these levels. You won't go too far wrong but try to get it in the mid-to low $50's.
BUY
BUY
July 8, 2009
Bio Pharma. Just came out with some promising test results on a bone cancer drug. Trading at about 15X earnings, which is very reasonable. Decent dividend.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
July 8, 2009
Bio Pharma. Just came out with some promising test results on a bone cancer drug. Trading at about 15X earnings, which is very reasonable. Decent dividend.
COMMENT
COMMENT
June 11, 2009
Very interested in the biotech space. This one has been sitting unnoticed for a little while. Even more interesting would be the Biotech HLDRs (BBH-N). (See comments under BBH-N).
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
June 11, 2009
Very interested in the biotech space. This one has been sitting unnoticed for a little while. Even more interesting would be the Biotech HLDRs (BBH-N). (See comments under BBH-N).
TOP PICK
TOP PICK
April 21, 2009
Model $59.79. Drugs have been showing up. Get it before the numbers come in. Market selling off in light of expected earnings.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
April 21, 2009
Model $59.79. Drugs have been showing up. Get it before the numbers come in. Market selling off in light of expected earnings.
DON'T BUY
DON'T BUY
June 22, 2007
Stocks that under perform in a bull market tend to under perform more in a bear market. They have a decelerating growth rate. Expect there will be sales reduction over the next year.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
June 22, 2007
Stocks that under perform in a bull market tend to under perform more in a bear market. They have a decelerating growth rate. Expect there will be sales reduction over the next year.
COMMENT
COMMENT
April 16, 2007
From a technical perspective, he would look for it to carve out a double bottom, or a higher low.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
April 16, 2007
From a technical perspective, he would look for it to carve out a double bottom, or a higher low.
DON'T BUY
DON'T BUY
March 15, 2007
Can't get enthused about the pharmaceutical markets. The amount of government action, the pressures, the lawsuits, etc. makes it a high-risk area.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
March 15, 2007
Can't get enthused about the pharmaceutical markets. The amount of government action, the pressures, the lawsuits, etc. makes it a high-risk area.
SELL
SELL
June 27, 2006
There are concerns that the growth level in the business indicates there has been a dissatisfaction and lack of interest in pharmaceutical and drug companies. Below the 200 day moving average.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
June 27, 2006
There are concerns that the growth level in the business indicates there has been a dissatisfaction and lack of interest in pharmaceutical and drug companies. Below the 200 day moving average.
BUY
BUY
February 1, 2006
One of the great pharmaceutical stories. Fabulous company. The whole industry has been lackluster for last 2/3 years. This has been driven by patent litigation and lawsuits. Probably a reasonable price right now.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
February 1, 2006
One of the great pharmaceutical stories. Fabulous company. The whole industry has been lackluster for last 2/3 years. This has been driven by patent litigation and lawsuits. Probably a reasonable price right now.
BUY
BUY
October 26, 2005
The biotech sector has done well this year. This stock has held up well during the market correction. Looks like it has started into a longer climb higher. Because of the current market risk, you have to pick your entries.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
October 26, 2005
The biotech sector has done well this year. This stock has held up well during the market correction. Looks like it has started into a longer climb higher. Because of the current market risk, you have to pick your entries.
SELL
SELL
August 4, 2005
Model price has been the same at $53.30. The increase in the stock price has been a little overdone.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
August 4, 2005
Model price has been the same at $53.30. The increase in the stock price has been a little overdone.
BUY
BUY
March 17, 2005
Likes the stock. The sector has been weak over the last few months. Has a pretty full pipeline of stuff that could surprise us. Trades at a reasonable multple.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
March 17, 2005
Likes the stock. The sector has been weak over the last few months. Has a pretty full pipeline of stuff that could surprise us. Trades at a reasonable multple.
DON'T BUY
DON'T BUY
March 11, 2005
Majority of money is from 3 products. Want's more diversificaion. Good balance sheet though.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
March 11, 2005
Majority of money is from 3 products. Want's more diversificaion. Good balance sheet though.
TOP PICK
TOP PICK
August 13, 2004
Likes the health-care sector. One of the top companies. Has underperformed for a long time, but they are willing to be patient.
Show full opinionHide full opinion
Amgen Inc. (AMGN-Q)
August 13, 2004
Likes the health-care sector. One of the top companies. Has underperformed for a long time, but they are willing to be patient.
Showing 61 to 75 of 105 entries